Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
03/2004
03/03/2004EP1392296A1 Thiazolidinediones alone or in conbination with other therapeutic agents for inhibiting or reducing tumour growth
03/03/2004EP1392291A2 Tripeptidyl peptidase inhibitors
03/03/2004EP1392280A2 Arylsulfonamide ethers, and methods of use thereof
03/03/2004EP1307460B1 METHOD FOR THE PRODUCTION OF IMIDAZO-[1,2-c][2,3]-BENZODIAZEPINES AND INTERMEDIATES IN THE PRODUCTION THEREOF
03/03/2004EP1210345B1 Oxazole ppar antagonists
03/03/2004EP1045839B1 Novel amines as pharmaceutical agents
03/03/2004EP1038874B1 Oxime derivatives and agricultural chemicals containing the same
03/03/2004EP0882714B1 Substituted vinylpyridine derivatives and drugs containing the same
03/03/2004EP0853617B1 Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives
03/03/2004CN1479728A Pexoxisome proliferator activated receptor alpha agonists
03/03/2004CN1479618A Treatment of sexual dysfunction using boonbesin antagonist
03/03/2004CN1478778A 抗真菌剂及其制备方法和中间体 Antifungal agent and its preparation method and intermediates
03/03/2004CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor
03/03/2004CN1140513C Phenylsulphenyl ureas, process for their preparation and their use as herbicides and plant-growth regulators
03/02/2004US6699895 2-aminothiazoline derivatives and process for preparing the same
03/02/2004US6699879 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
03/02/2004US6699870 Phthalazine compounds and therapeutic agents for erectile dysfunction
03/02/2004US6699867 4-(4-Methyl-piperazin-1-ylmethyl)-4,5-dihydrothiazol-2-ylamine
03/02/2004US6699866 For therapy of addiction, anxiety, depression, sexual dysfunction, hypertension, migraine, alzheimer's disease, obesity, emesis, psychosis, analgesia, schizophrenia, parkinson's disease, restless leg syndrome, sleeping disorders
03/02/2004US6699865 Protein kinase inhibitors, for treating cancer inflammatory disorders, restenosis, and cardiovascular disease.
03/02/2004US6699860 Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists
03/02/2004US6699857 Tetrahydroquinolinyl 6-methyldihydrothiadiazinone derivatives and use thereof
03/02/2004US6699856 Pyrazinones, compositions containing such compounds and methods of use
03/02/2004US6699854 2-substituted 4-heteroaryl- pyrimidines, inhibitors of cyclin-dependent kinases (cdks)
03/02/2004US6699853 Protecting useful plants against the undesirable action of harmful insects, acarids and nematodes,
03/02/2004US6699818 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
03/02/2004US6699651 Base precursors for use in a photothermographic element
03/02/2004CA2138289C N-substituted azabicycloheptane derivatives, the preparation and use thereof
02/2004
02/26/2004WO2004016741A2 Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use
02/26/2004WO2004016622A1 Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents
02/26/2004WO2004016604A2 Azabicyclic compounds are central nervous system active agents
02/26/2004WO2004016601A1 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
02/26/2004WO2004016600A1 Novel use of benzothiazole derivatives
02/26/2004WO2004016592A1 Prenylation inhibitors and methods of their synthesis and use
02/26/2004WO2004016587A1 Nitrogen-containing compounds
02/26/2004WO2003099337A3 Inclusion complexes of rosiglitazone
02/26/2004WO2003099211A3 Mitotic kinesin inhibitors
02/26/2004WO2003062388A3 Inhibition of rna function
02/26/2004WO2003057144A3 Change inhibitors of dipeptidyl peptidase iv
02/26/2004WO2003050261A3 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
02/26/2004WO2002098424B1 Novel anti-infectives
02/26/2004WO2002088120B1 Method for obtaining pioglitazone as an antidiabetic agent
02/26/2004US20040039038 Biaromatic compound activators of PPARy-type receptors
02/26/2004US20040039037 Heterocyclic compounds and uses thereof
02/26/2004US20040039035 A (Ar1-X-Ar2) compound, where Ar1 and Ar2= aryl, heteroaryl or fused arylheteroaryl, X= secondary or tertiary amine, -C(=O)S, -CH=CHSO2 and -SO2N(R)2, and R=H or alkyl, useful for treating contact hypersensitivity
02/26/2004US20040039033 Administering (1-phenyl-2-heteroaryl)ethyl-guanidine compounds for treating ischemic conditions including myocardial infarction, congestive heart failure, and cardiac arrhythmias
02/26/2004US20040039029 Thiazolyl urea compounds and methods of uses
02/26/2004US20040039026 Macromolecules such as (12R,13S,15S)-cyclopropyl 5-methyl-pyridine epothilone A, used as tubulin polymerization promoters and for cytolysis cancer cells; antiproliferative agents
02/26/2004US20040039016 HIV protease inhibitors
02/26/2004US20040039008 Peroxy compounds such as adamantane-2-spiro-3'-8'-((1'S)-10'-camphorsulfonyl)-1',2',4'-trioxa-8' -azaspiro(4.5)decane, used for prophylaxis of malaria or schistosomiasis infections
02/26/2004US20040038998 Aminopiperidine quinolines and their azaisosteric analogues with antibacterical activity
02/26/2004US20040038992 2-thio-(or oxy)-5-amino-1,3,4-thiadiazoles or oxadiazoles
02/26/2004US20040038990 Aminothiazole derivatives
02/26/2004US20040038987 Novel cyclic diamine compounds and medicine containing the same
02/26/2004US20040038979 Novel 6-heteroarylphenanthridines
02/26/2004US20040038973 Treating osteoarthritis or rheumatoid arthritis
02/26/2004US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc.
02/26/2004US20040038968 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl) thiazolidine-2,4-dione potassium salt
02/26/2004US20040038941 Compounds for the treatment of inflammatory disorders
02/26/2004US20040038858 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours
02/26/2004CA2495589A1 Azabicyclic compounds are central nervous system active agents
02/26/2004CA2495492A1 Novel use of benzothiazole derivatives
02/25/2004EP1391952A2 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials
02/25/2004EP1391456A1 2-iminoimidazole derivative (2)
02/25/2004EP1391454A1 Substituted benzamide compounds with antihypertensive activity
02/25/2004EP1391451A1 2-iminopyrrolidine derivates
02/25/2004EP1390363A2 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
02/25/2004EP1390353A1 Triazole-derived kinase inhibitors and uses thereof
02/25/2004EP1390350A1 Novel compounds
02/25/2004EP1390034A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
02/25/2004EP1263756B1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
02/25/2004EP1211246B1 Pyrimidine derivatives and herbicides containing the same
02/25/2004EP1042296B1 Substituted isoquinoline derivatives and their use as anticonvulsants
02/25/2004EP1040108B1 Ortho-anthranilamide derivatives as anti-coagulants
02/25/2004EP0981526B1 Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
02/25/2004EP0906297B1 1,2,4-benzothiadiazine derivatives, their preparation and use
02/25/2004CN1478084A Compounds useful in treatment of inflammatory diseases
02/25/2004CN1478078A Nitrogenous aromatic ring compounds
02/25/2004CN1478075A Chemical process and new intermediates
02/25/2004CN1477960A EPA receptor inhibitors to treat rheumatoid arthritis
02/25/2004CN1477946A Method of repairing or restoring damaged or defective hair
02/25/2004CN1139580C Substituted benzylamines and their use for treatment of depression
02/25/2004CN1139577C Improved process for preparation of unsymmetrical 4,6-bis(aryloxy) pyrimidine compounds
02/24/2004US6696482 Formulations for hydrophobic pharmaceutical agents
02/24/2004US6696473 Heterocyclic modulators of nuclear receptors
02/24/2004US6696469 For treatment of diseases or pathological conditions in which endothelial dysfunction is known; atherosclerosis, dyslipidaemia, diabetes
02/24/2004US6696459 Using high affinity, high selectivity quinoline derivativesw
02/24/2004US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments
02/24/2004US6696451 Dihydropyrimidines
02/24/2004US6696437 Polymerase inhibitors comprising heterocyclic amides such as 2-pyridin-2-ylbenzimidazole-4-carboxamide, used for prophylaxis of neurodegenerative disorders, damage to hearts or brains, and as anticarcinogenic agents
02/19/2004WO2004015131A2 Hepatitis c virus assays
02/19/2004WO2004014919A1 Epothilone derivatives
02/19/2004WO2004014915A1 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
02/19/2004WO2004014904A1 Antiproliferative 2-(heteroaryl)-aminothiazole compounds, pharmaceutical compositions and methods for their use
02/19/2004WO2004014903A1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
02/19/2004WO2004014902A2 Compounds having an activity at metabotropic glutamate receptors
02/19/2004WO2004014900A1 Benzimidazoles and benzothiazoles as inhibitors of map kinase
02/19/2004WO2004014885A1 Amino benzothiazole compounds with nos inhibitory activity
02/19/2004WO2004014884A1 Thiazole derivatives
02/19/2004WO2004014881A2 '1,2,4'oxadiazoles as modulators of metabotropic glutamate receptor-5